Early Circulating Tumor DNA Shedding Kinetics for Prediction of Platinum Sensitivity in Patients With Small Cell Lung Cancer

A >2-fold decrease in ctDNA concentration was observed by C2D1 in all patients who were sensitive to platinum-based therapy and was associated with longer PFS and OS.

Authors

Institutions

Publication Details

Journal
JCO Precision Oncology
Published
2024-09-01
DOI
https://doi.org/10.1200/po.24.00216
Citations
8
Primary Topic
Lung Cancer Research Studies
Type
article
Field-Weighted Citation Impact
1.98

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Early Circulating Tumor DNA Shedding Kinetics for Prediction of Platinum Sensitivity in Patients With Small Cell Lung Cancer

Ritika Kundra, Maximilian Diehn, Angela BY Hui, Michael David Offin et al.
8 citations
JCO Precision Oncology
Lung Cancer Research Studies
1.98
article

Early Circulating Tumor DNA Shedding Kinetics for Prediction of Platinum Sensitivity in Patients With Small Cell Lung Cancer

Ritika Kundra, Maximilian Diehn, Angela BY Hui, Michael David Offin, Ash A. Alizadeh, Emily S. Lebow, Michelle S. Ginsberg, Everett J. Moding, Pedram Razavi, Emily G. Hamilton, Yonina R. Murciano‐Goroff, Rene F. Bonilla, Larry Norton, Bob T. Li, Charles M. Rudin, Andreas Rimner, Viola Allaj, Alexander Edward Dela Cruz Drilon, David R. Jones, Jacob J. Chabon, W. Victoria Lai, José de Arimateia Batista Araújo-Filho, James M. Isbell, Jorge S. Reis-Filho, Daniel Gomez
article en
8 citations

Abstract

A >2-fold decrease in ctDNA concentration was observed by C2D1 in all patients who were sensitive to platinum-based therapy and was associated with longer PFS and OS.

JCO Precision OncologyVol. 8(8)
Memorial Sloan Kettering Cancer Center (US), California Institute for Regenerative Medicine (US), Cornell University (US), Weill Cornell Medicine (US), Stanford University (US)
Conquer Cancer Foundation, Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, Tobacco-Related Disease Research Program, American Society of Clinical Oncology, Virginia and D.K. Ludwig Fund for Cancer Research, Celgene, Memorial Sloan-Kettering Cancer Center, Varian Medical Systems, Regeneron Pharmaceuticals, Intuitive Surgical, Jazz Pharmaceuticals, Andrew Sabin Family Foundation, Georgia Clinical and Translational Science Alliance, Mirati Therapeutics, Revolution Medicines, Invitae, National Institutes of Health, Genentech, School of Medicine, Stanford University, Loxo Oncology, National Cancer Institute, Daiichi Sankyo Europe
Good health and well-being
Openalex Percentile: Top 11%
Lung Cancer Research Studies
1.98
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.